The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer.

Subjects

Subjects :

Adult
Aged
Aged, 80 and over
Anemia etiology
Antineoplastic Combined Chemotherapy Protocols adverse effects
Blood Cell Count
Carcinoma, Non-Small-Cell Lung pathology
Carcinoma, Non-Small-Cell Lung physiopathology
Cisplatin administration & dosage
Cisplatin adverse effects
Clinical Protocols
Female
Humans
Lung Neoplasms pathology
Lung Neoplasms physiopathology
Male
Middle Aged
Neoplasm Metastasis
Neutropenia etiology
Vinblastine administration & dosage
Vinblastine adverse effects
Vinblastine analogs & derivatives
Vinorelbine
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carcinoma, Non-Small-Cell Lung diagnosis
Carcinoma, Non-Small-Cell Lung drug therapy
Lung Neoplasms diagnosis
Lung Neoplasms drug therapy

Details

Language :

English

ISSN :

1872-8332

Volume :

69

Issue :

3

Database :

MEDLINE

Journal :

Lung cancer (Amsterdam, Netherlands)

Publication Type :

Report

Accession number :

20655614

Full Text :

https://doi.org/10.1016/j.lungcan.2010.06.017